Endo International plc, et al.
Case Number:
7:22-bk-22549
Court:
Nature of Suit:
Firms
- Klehr Harrison
- Porzio Bromberg
- ArentFox Schiff
- Tucker Arensberg
- Carter Ledyard
- Godfrey & Kahn
- WilmerHale
- Davis Polk
- Husch Blackwell
- Simpson Thacher & Bartlett LLP
- Katten Muchin
- Potter Anderson
- Norton Rose
- Kurzman Eisenberg
- Obermayer Rebmann
- Chipman Brown
- ASK LLP
- Kohner Mann
- Carlton Fields
- Gilbert LLP
- McGrail & Bensinger
- Herzfeld Suetholz
- Pachulski Stang
- Kramer Levin
- Bielli & Klauder
- Cohen Weiss
- Robinson & Cole
- Kline & Specter
- ArentFox Schiff LLP
- Connell Foley
- Rubin LLC
- Perkins Coie
- Davidson Fink
- Saul Ewing
- Foran Glennon
- Taft Stettinius
- Stutzman Bromberg
- Schiller Knapp
- Holwell Shuster
- Fleischer Fleischer
- Brown & Connery
- Cullen & Dykman
- Duane Morris
- Kirkland & Ellis
- Aldridge Pite
- Brown Rudnick
- Shafferman & Feldman
- Fox Rothschild
- Troutman
- Foley & Lardner
- K&L Gates
- Barton LLP
- O'Melveny & Myers
- Glenn Agre
- White and Williams
- McKool Smith
- Weltman Weinberg
- Burke Warren
- Orrick Herrington
- Chiesa Shahinian
- Levenfeld Pearlstein
- Squire Patton
- Stevens & Lee
- Covington & Burling
- Togut Segal
- Kane Russell
- Miller Nash LLP
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Nelson Mullins
- Lemery Greisler
- Nixon Peabody
- Dentons
- Kelley Drye
- Masuda Funai
- Freshfields
- Sills Cummis
- Haynes Boone
- Skadden Arps
- Phillips Lytle
- Tarter Krinsky
- Jones Day
- Cooley LLP
- Paul Weiss
- Klestadt Winters
- Hunton Andrews
- Wachtell Lipton
- Stark & Stark
- Seward & Kissel
- Goldman Ismail
- McCarter & English
- Linebarger Goggan
- Davidson Bowie
- Warner Norcross
- Kelly & Brennan
- Fishman Haygood
- Young Conaway
- Pillsbury Winthrop
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Beck Chaet
- Shipman & Goodwin
- Dickie McCamey
- McElroy Deutsch
- Stranch Jennings
- Blank Rome
- Bond Schoeneck
- Hodgson Russ
- Jenner & Block
- Frejka PLLC
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Teikoku Pharma USA Inc.
- Medco Health Solutions Inc.
- Henry Schein Inc.
- AstraZeneca PLC
- Merck & Co. Inc.
- Dayforce Inc.
- Life Technologies Corporation
- PCI Pharma Services
- Toyota Industries Commercial Finance Inc.
- Everest Group Ltd.
- Consolidated Edison Inc.
- Evoqua Water Technologies LLC
- Altaris Capital Partners LLC
- Collegium Pharmaceutical Inc.
- Wilmington Trust Corp.
- Endo International PLC
- Computershare Ltd.
- Province LLC
- Express Scripts Holding Co.
- Auxilium Pharmaceuticals, Inc.
- Amneal Pharmaceuticals Inc.
- Syntax Systems Ltd.
- Ernst & Young LLP
- Ford Motor Co.
- The Hartford Financial Services Group Inc.
- AXA XL Ltd.
- Ahold Delhaize
- The Cigna Group
- Walmart Inc.
- United BioSource Corp.
- Lazard Ltd.
- Par Pharmaceutical Cos. Inc.
- Ducera Partners LLC
- Berkeley Research Group LLC
- Optum Inc.
- Dundon Advisers LLC
- Patheon Inc.
- AIS Portfolio Services LLC
- OptumRx Inc.
- JPMorgan Chase & Co.
- Anchen Pharmaceuticals Inc.
- Canon Financial Services Inc.
- Alvarez & Marsal Holdings LLC
- UMB Financial Corp.
- SAP AG
- AbbVie Inc.
- Cardinal Health Inc.
- CVS Health Corp.
- DTE Energy Co.
- PECO Energy Co.
- Evidera
- Liberty Mutual Insurance Group
- Canon Inc.
- Grant Thornton LLP
- Novitium Pharma LLC
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Johnson Controls International PLC
- KPMG International
- SAS Institute Inc.
- Ironshore Inc.
- Ahold Delhaize USA
- Lexington Insurance Co.
- Cencora Inc.
- Constellation Energy Corp.
- Grunenthal Group
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Aspen Insurance Holdings Ltd.
- U.S. Bancorp
- Pfizer Inc.
- Johnson & Johnson
- American Federation of State County & Municipal Employees
- PricewaterhouseCoopers LLP
- Jefferies Financial Group Inc.
- United Steelworkers
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Missouri Department of Revenue
- National Labor Relations Board
- Rochester City School District
- State of Indiana
Sectors & Industries:
-
April 02, 2025
PE Firm TPG Wants Endo Trust's Transfer Suit Tossed
Private equity firm TPG Capital is seeking the dismissal of a lawsuit that aims to claw back billions of dollars reaped in an allegedly unfair deal with Endo International PLC before the drugmaker went bankrupt.
-
August 19, 2024
TPG Dumped Opioid Co. On 'Unsuspecting' Endo, Suit Says
After pushing Par Pharmaceutical to grow its market share in generic opioids and disregard federal requirements to report suspicious orders, TPG Capital saw other opioid manufacturers being inundated with litigation and sold Par to "an unsuspecting" Endo International PLC, according to a lawsuit filed in New York bankruptcy court.
-
August 16, 2024
McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says
Consulting giant McKinsey & Co. should pay at least $1.5 billion to cover costs pharmaceutical developer Endo International racked up defending against claims that it helped drive the opioid crisis, an unsecured creditors' trustee has said, telling a New York bankruptcy judge the consultant's marketing and sales advice lit a "ticking time bomb" that sent Endo into Chapter 11.
-
April 22, 2024
Endo Creditor Trust Asks For $50M In Litigation Financing
The committee of unsecured creditors in the Chapter 11 case of pharmaceutical company Endo International asked a New York bankruptcy judge Monday for permission to enter into a $50 million secondary financing facility to help the creditor trust created under the company's bankruptcy plan pursue litigation and settlements of potential claims.
-
March 20, 2024
Endo Plan To Trim $5B In Debt Confirmed By NY Judge
Drugmaker Endo International got a New York bankruptcy judge's approval for its Chapter 11 plan that aims to cut more than $5 billion in debt and hand over ownership to its lenders, roughly a month after it finalized a $465 million deal to resolve criminal and civil opioid claims.
-
February 29, 2024
Bankrupt Endo To Pay $465M To Resolve Opioid Claims
Drugmaker Endo International has agreed to pay as much as $465 million to resolve criminal and civil claims stemming from its sale and marketing of a powerful opioid, and will turn over its assets to a group of secured lenders who will operate the company under a new corporate structure.
-
February 02, 2024
Drugmaker Endo Wants To Extend Opioid Suit Pause
Endo has asked a New York bankruptcy judge to pause the opioid litigation leveled against it for five more months, asserting that the pharmaceutical company made "wide-ranging progress" in its Chapter 11 case and expects to have a reorganization plan confirmed by March.
-
September 21, 2023
Skadden Nabs $19M Fee For 4 Months' Work On Endo Ch. 11
Skadden Arps Slate Meagher & Flom LLP was cleared Thursday by a New York judge to be paid over $19 million for its work from January to April 2023 on the Chapter 11 bankruptcy of pharmaceutical company Endo International PLC.
-
July 20, 2023
Endo International Wins More Support For $6B Ch. 11 Sale
Bankrupt pharmaceutical company Endo International PLC told a New York judge Thursday that it has resolved objections from key stakeholders in its Chapter 11 case and garnered increased support for a $6 billion sale of its assets to a group of debtholders.
-
July 19, 2023
Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan
Bankrupt pharmaceutical company Endo International asked a New York bankruptcy court Tuesday to approve a settlement with distributors, manufacturers and pharmacies over indemnification of claims in opioid litigation that should remove an obstacle blocking the sale of Endo's assets.